Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in NVCR — NovoCure Ltd

CIK 1446194 BALA CYNWYD, PA
Back to NVCR Full portfolio

Position in NVCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,639,796
+$488,409 QoQ
Shares Held
174,244
-11.7% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 217 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Derivatives in NVCR

reported options exposure · as of Jun 30, 2026
CallValue
$3,011,820
CallShares
198,800
PutValue
$1,360,470
PutShares
89,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $397,083,529 across 81 Medical Devices names. NVCR ranks #17 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 826,420 $74,989,349
2 BSX
Boston Scientific Corp
 1,661,950 $70,932,025
3 DXCM
Dexcom Inc
 1,043,864 $70,304,239
4 MDT
Medtronic plc
 410,840 $32,140,013
5 SYK
Stryker Corp
 76,719 $24,154,209
6 GEHC
GE HealthCare Technologies Inc.
 314,867 $20,154,636
7 TMDX
TransMedics Group, Inc.
 255,398 $16,963,535
8 PEN
Penumbra Inc
 29,149 $9,203,796

All Filings in NVCR

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,639,796 174,244
2026-06-30 $1,360,470 89,800
2026-06-30 $3,011,820 198,800
2026-03-31 $2,151,387 197,375
2026-03-31 $6,969,460 639,400
2026-03-31 $6,159,590 565,100
2025-12-31 $2,638,404 204,053
2025-12-31 $6,757,218 522,600
2025-12-31 $3,429,036 265,200
2025-09-30 $1,231,276 95,300
2025-09-30 $1,796,138 139,020
2025-09-30 $6,271,368 485,400
2025-06-30 $1,023,500 57,500
2025-06-30 $5,706,680 320,600
2025-06-30 $5,122,323 287,771
2025-03-31 $4,269,511 239,591
2025-03-31 $6,928,416 388,800
2025-03-31 $1,407,780 79,000
2024-12-31 $5,507,040 184,800
2024-12-31 $11,821,660 396,700
2024-12-31 $2,253,327 75,615
2024-09-30 $2,049,093 131,100
2024-09-30 $2,430,465 155,500
2024-09-30 $1,583,834 101,333
2024-06-30 $2,490,702 145,400
2024-06-30 $2,381,070 139,000
2024-06-30 $3,210,880 187,442
2024-03-31 $9,654,072 617,663
2024-03-31 $3,549,573 227,100
2024-03-31 $3,752,763 240,100
2023-12-31 $5,783,882 387,400
2023-12-31 $3,605,639 241,503
2023-12-31 $3,459,281 231,700
2023-09-30 $4,623,745 286,300
2023-09-30 $4,227,553 261,768
2023-09-30 $697,680 43,200
2023-06-30 $11,464,167 276,245
2023-06-30 $13,184,550 317,700
2023-06-30 $10,304,450 248,300
2023-03-31 $9,935,128 165,200
2023-03-31 $6,771,162 112,590
2023-03-31 $5,574,978 92,700
2022-12-31 $1,388,515 18,930
2022-12-31 $16,188,345 220,700
2022-12-31 $11,178,540 152,400
2022-09-30 $2,534,464 33,357
2022-09-30 $10,903,130 143,500
2022-09-30 $8,464,172 111,400
2022-06-30 $10,793,350 155,300
2022-06-30 $13,385,700 192,600